PMID- 24425766 OWN - NLM STAT- MEDLINE DCOM- 20140527 LR - 20211021 IS - 1522-1555 (Electronic) IS - 0193-1849 (Print) IS - 0193-1849 (Linking) VI - 306 IP - 6 DP - 2014 Mar TI - Early mitochondrial dysfunction in glycolytic muscle, but not oxidative muscle, of the fructose-fed insulin-resistant rat. PG - E658-67 LID - 10.1152/ajpendo.00511.2013 [doi] AB - Although evidence that type 2 diabetes mellitus (T2DM) is accompanied by mitochondrial dysfunction in skeletal muscle has been accumulating, a causal link between mitochondrial dysfunction and the pathogenesis of the disease remains unclear. Our study focuses on an early stage of the disease to determine whether mitochondrial dysfunction contributes to the development of T2DM. The fructose-fed (FF) rat was used as an animal model of early T2DM. Mitochondrial respiration and acylcarnitine species were measured in oxidative (soleus) and glycolytic [extensor digitorum longus (EDL)] muscle. Although FF rats displayed characteristic signs of T2DM, including hyperglycemia, hyperinsulinemia, and hypertriglyceridemia, mitochondrial content was preserved in both muscles from FF rats. The EDL muscle had reduced complex I and complex I and II respiration in the presence of pyruvate but not glutamate. The decrease in pyruvate-supported respiration was due to a decrease in pyruvate dehydrogenase activity. Accumulation of C14:1 and C14:2 acylcarnitine species and a decrease in respiration supported by long-chain acylcarnitines but not acetylcarnitine indicated dysfunctional beta-oxidation in the EDL muscle. In contrast, the soleus muscle showed preserved mitochondrial respiration, pyruvate dehydrogenase activity, and increased fatty acid oxidation, as evidenced by overall reduced acylcarnitine levels. Aconitase activity, a sensitive index of reactive oxygen species production in mitochondria, was reduced exclusively in EDL muscle, which showed lower levels of the antioxidant enzymes thioredoxin reductase and glutathione peroxidase. Here, we show that the glycolytic EDL muscle is more prone to an imbalance between energy supply and oxidation caused by insulin resistance than the oxidative soleus muscle. FAU - Warren, Blair E AU - Warren BE AD - Campus Saint-Jean, University of Alberta, Edmonton, Alberta, Canada; FAU - Lou, Phing-How AU - Lou PH FAU - Lucchinetti, Eliana AU - Lucchinetti E FAU - Zhang, Liyan AU - Zhang L FAU - Clanachan, Alexander S AU - Clanachan AS FAU - Affolter, Andreas AU - Affolter A FAU - Hersberger, Martin AU - Hersberger M FAU - Zaugg, Michael AU - Zaugg M FAU - Lemieux, Helene AU - Lemieux H LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140114 PL - United States TA - Am J Physiol Endocrinol Metab JT - American journal of physiology. Endocrinology and metabolism JID - 100901226 RN - 0 (Dietary Carbohydrates) RN - 0 (Fatty Acids) RN - 0 (Pyruvate Dehydrogenase Complex) RN - 0 (Reactive Oxygen Species) RN - 0 (acylcarnitine) RN - 30237-26-4 (Fructose) RN - 3KX376GY7L (Glutamic Acid) RN - 8558G7RUTR (Pyruvic Acid) RN - EC 4.2.1.3 (Aconitate Hydratase) RN - S7UI8SM58A (Carnitine) SB - IM EIN - Am J Physiol Endocrinol Metab. 2014 Dec 15;307(12):E1166 MH - Aconitate Hydratase/metabolism MH - Animals MH - Carnitine/analogs & derivatives/metabolism MH - Diabetes Mellitus, Type 2/etiology/*metabolism/physiopathology MH - Dietary Carbohydrates/adverse effects MH - Disease Progression MH - Energy Metabolism MH - Fatty Acids/metabolism MH - Fructose/adverse effects MH - Glutamic Acid/metabolism MH - *Glycolysis MH - *Insulin Resistance MH - Male MH - Mitochondria, Muscle/*metabolism MH - Muscle, Skeletal/*metabolism MH - *Oxidative Phosphorylation MH - Prediabetic State/etiology/*metabolism/physiopathology MH - Pyruvate Dehydrogenase Complex/metabolism MH - Pyruvic Acid/metabolism MH - Rats MH - Rats, Sprague-Dawley MH - Reactive Oxygen Species/metabolism PMC - PMC3948982 OTO - NOTNLM OT - aconitase OT - fatty acid oxidation OT - insulin resistance OT - mitochondrial dysfunction OT - sirtuin-3 OT - skeletal muscle OT - type 2 diabetes EDAT- 2014/01/16 06:00 MHDA- 2014/05/28 06:00 PMCR- 2015/03/15 CRDT- 2014/01/16 06:00 PHST- 2014/01/16 06:00 [entrez] PHST- 2014/01/16 06:00 [pubmed] PHST- 2014/05/28 06:00 [medline] PHST- 2015/03/15 00:00 [pmc-release] AID - ajpendo.00511.2013 [pii] AID - E-00511-2013 [pii] AID - 10.1152/ajpendo.00511.2013 [doi] PST - ppublish SO - Am J Physiol Endocrinol Metab. 2014 Mar;306(6):E658-67. doi: 10.1152/ajpendo.00511.2013. Epub 2014 Jan 14.